A phase I/II randomized, double-blind, placebo-controlled, dose-ranging study evaluating the efficacy, safety and pharmacokinetics of ravuconazole in the treatment of onychomycosis
AK Gupta, C Leonardi, RR Stoltz, PF Pierce, B Conetta, the Ravuconazole onychomycosis groupVolume:
19
Year:
2005
Language:
english
Pages:
7
DOI:
10.1111/j.1468-3083.2005.01212.x
File:
PDF, 156 KB
english, 2005